期刊文献+

β-环糊精对氯诺昔康的包合作用 被引量:1

Inclusions of Lornoxicam by β-Cyclodextrin and Its Derivatives
在线阅读 下载PDF
导出
摘要 采用荧光光谱、差热扫描和核磁共振法研究了不同酸度和温度下β-环糊精(β-CD)、羟丙基-β-环糊精(HP-β-CD)和磺丁醚-β-环糊精(SBE-β-CD)对氯诺昔康(LX)的包合特性。结果表明,3种环糊精与氯诺昔康均形成1∶1的包合物。以包合常数作为包合稳定性的量度,包合稳定性为SBE-β-CD>HP-β-CD>β-CD。 The inclusions of lornoxicam(LX) by β-cyclodextrin(β-CD),hydroxypropyl-β-cyclodextrin(HP-β-CD),and sulfobutyl ether-β-cyclodextrin(SBE-β-CD) were studied by fluorescence spectroscopy,differential scanning calorimetry(DSC) and NMR at different pH and temperature.The results showed that the 1∶ 1 inclusion compounds were formed between lornoxicam and CDs.Based on the formation constants,the interactions between lornoxicam and the three CDs follow an order of SBE-β-CDHP-β-CDβ-CD.
出处 《应用化学》 CAS CSCD 北大核心 2011年第4期421-425,共5页 Chinese Journal of Applied Chemistry
基金 山西省科技厅自然科学基金(20051029)资助项目
关键词 氯诺昔康 Β-环糊精 荧光光谱 差热扫描 1HNMR lornoxicam β-cyclodextrin fluorescence spectroscopy DSC NMR
  • 相关文献

参考文献8

  • 1王京燕,王洪权.新的非甾体抗炎药物氯诺昔康[J].解放军药学学报,2002,18(4):215-217. 被引量:40
  • 2Pruss T P, Stroissing H, Radhofer W S,et al. Overview of the Pharmacological Properties, Pharmacokinetics and Animal Safety Assessment of Lornoxicam [ J ]. Postgrad Med, 1990,66 ( Suppl. 4 ) : 18-21.
  • 3Arima H,Yunomae K, Miyake K,et al. Comparative Studies of the Enhancing Effects of Cyclodextrins on the Solubility and Oral Bioavailability of Tacrolimus in Rats [ J ]. J Pharm Sci ,2001,90 (6) :690-701.
  • 4代国飞,王明伟.环糊精及其衍生物的药学应用进展[J].中国新药杂志,2005,14(11):1261-1264. 被引量:23
  • 5陈海琼,宋民宪,黄珍.羟丙基-β-环糊精的研究概况[J].时珍国医国药,2006,17(11):2303-2303. 被引量:8
  • 6Partyka M,Au B H,Evans C H. Cyclodextrins as Phototoxicity Inhibitors in Drug Formulations:Studies on Model Systems Involving Naproxen and β-Cyclodextrin [ J]. J Photochem Photobiol A, 2001,140 ( 1 ) :67-74.
  • 7王亚南,王洪权.2-羟丙基-β-环糊精对氯诺昔康的增溶作用[J].解放军药学学报,2006,22(2):146-148. 被引量:9
  • 8Gino C Catena, Frank V Bright. Thermodynamic Study on the Effects of β-Cyclodextrin Inclusion with Anilinonaphthalenesulfonates [ J ]. Anal Chem, 1989,61 ( 8 ) : 905-909.

二级参考文献48

  • 1杨造萍.环糊精及其衍生物在药物分析中的应用[J].国外医学(药学分册),1994,21(5):257-261. 被引量:2
  • 2蔡溱,高申.β-环糊精及其衍生物在药剂学上的应用与研究进展[J].国外医学(药学分册),1996,23(1):12-15. 被引量:14
  • 3丁平田,吴雪梅.药物制剂的新型辅料2-羟丙基-β-环糊精[J].国外医药(合成药.生化药.制剂分册),1996,17(2):107-111. 被引量:62
  • 4毕殿洲.药剂学(第4版)[M].北京:人民卫生出版社,1999.56.
  • 5[1]Pruss T P,Stroissing H,Radhofer W S,et al.Overview of the pharmacological properties,pharmacokinetics and animal safety assessment of lornoxicam[J].Postgrad.Med.J,1990,66:Suppl.4,18
  • 6[2]Urano H,Itoga H,Fukushima K,et al.Disposition of lornoxicam (2)-tissue distribution, foeto-placental transfer and tranfer into milk after single administration to rats[J].Kiso To Rinsho,1997,31(4):21
  • 7[3]Hitzenberger G,Radhofer Welte S,Takacs F,et al.Pharmacokinetics of lornoxicam in man[J].Postgrad.Med.J,1990,66:Suppl.4,22
  • 8[4]Turner P,Johnston-A.Clinical pharmacokinetic studies with lornoxicam[J].Postgrad.Med.J,1990,66:Suppl.4,28
  • 9[5]Atzpodien E,Mehdi N,Clarke D,et al.Subacute and chronic oral toxicity of lornoxicam in cynomolgus monkeys[J].Food-Chem-Toxocol,1997,35:ISS 5,465
  • 10[6]Pohlmeyer E G,Mehdi N,Clarke D,et al.Evaluation of chronic oral toxicity and carcinogenic potential of lornoxicam in rat[J].Food-Chem-Toxocol,1997,35:ISS 9,909

共引文献72

同被引文献13

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部